Differential Gastrointestinal Effects of Who-Step III Opioids in Low Back Pain Patients with vs. Without Constipation: Post-Hoc Analysis of Data from a 12-Week Prospective, Open-Label Blinded Endpoint Streamlined Study
Open Access
- 10 September 2015
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Anesthesiology
- Vol. 2 (2), 037-051
- https://doi.org/10.17352/2455-3476.000015
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) TrialThe American Journal of Gastroenterology, 2013
- Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsBMC Clinical Pharmacology, 2010
- The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a reviewAdvances in Therapy, 2010
- Outcomes Associated with Opioid Use in the Treatment of Chronic Noncancer Pain in Older Adults: A Systematic Review and Meta‐AnalysisJournal of the American Geriatrics Society, 2010
- Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic painInternational Journal of Clinical Practice, 2010
- Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practiceCurrent Medical Research and Opinion, 2010
- Opioid receptors in the gastrointestinal tractRegulatory Peptides, 2009
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)Pain Medicine, 2009
- Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInternational Journal of Clinical Practice, 2007
- Grading the severity of chronic painPain, 1992